Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Royalty Pharma plc company logo
Royalty Pharma plc logo

Royalty Pharma plc (RPRX)

Summary

As of today, RPRX price is $45.68, down -3.69% on
RPRX price is currently -19.15% below its historical high of $56.50 set on
RPRX current market cap is $27B, up +84.73% over the past 365 days
RPRX current PE ratio is 25.65
RPRX current annual revenue is $2.38B, up +5.06% year-over-year
The next earnings release for RPRX is on

Profile

Company profile for Royalty Pharma plc (RPRX)
MetricValue
Full NameRoyalty Pharma plc
TickerNASDAQ: RPRX
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websiteroyaltypharma.com
Employees75

Key Metrics

Royalty Pharma plc Key Details
MetricDateValue
Price$45.68
Price, 1D Change-3.69%
Market Cap$27B
TTM Dividend Yield1.96%
PE Ratio25.65
Beta0.36
Revenue$2B
Revenue, 1Y Change+5.06%
EPS$1.78
EPS, 1Y Change-6.83%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Royalty Pharma plc chart

Events

Royalty Pharma plc Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.24
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

RPRX Estimates
MetricDateValue
EPS$1.78
EPS EstimateN/A$5.06
EPS Est. ChangeN/A+184.12%
Revenue$2.38B
Revenue EstimateN/A$3.41B
Revenue Est. ChangeN/A+43.48%
Current Price$45.68
Price Target-$51.00
Price Tgt. Change-+11.65%

🔒 Log In To Unlock Full Data

EPS

RPRX EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$4.05$1.91-52.78%
$4.64$1.78-61.59%
$5.06N/A+184.12%
$5.45N/A+205.79%
RPRX EPS reported versus estimate values chart

Revenue

RPRX revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$2.70B$2.26B-16.32%
$3.21B$2.38B-25.99%
$3.41BN/A+43.48%
$3.63BN/A+52.58%
RPRX revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

RPRX Performance
MetricDateValue
Price, 1Y+37.26%
Price, 3Y+29.96%
Market Cap, 1Y+84.73%
Market Cap, 3Y+71.01%
Revenue, 1Y+5.06%
Revenue, 3Y+6.30%
EPS, 1Y-6.83%
EPS, 3Y+1,721.47%

🔒 Log In To Unlock Full Data

Technical Indicators

RPRX Technical Indicators
MetricDateValue
Current Price$45.68
SMA 200$37.94
SMA 200 vs Price-16.95%
SMA 50$42.30
SMA 50 vs Price-7.40%
Beta0.36
ATR$1.00
14-Day RSI59.11
10-Day Volatility26.74%
1-Year Volatility23.03%

Dividends

RPRX Dividends
MetricDateValue
Last Paid$0.24
UpcomingN/AN/A
Dividend Yield1.93%
Total Dividend$0.88
$378.25M
28.56%

🔒 Log In To Unlock Full Data

Income & Profitability

RPRX Income & Profitability
MetricDateValue
Revenue$2.38B
EPS$1.78
Gross Profit$2.37B
Gross Margin99.84%
Operating Profit$1.56B
Operating Margin65.58%
Net Income$1.32B
Net Margin55.68%
EBITDA$1.56B

🔒 Log In To Unlock Full Data

Financial Health

RPRX Financial Health
MetricDateValue
Debt To Equity1.38
2.40
2.40
-
7
2.22

Valuations

RPRX Valuations
MetricDateValue
PE Ratio25.65
11.20
4.11
22.39
N/A-

Balance Sheet

RPRX Balance Sheet
MetricDateValue
Book Value$6.48B
$637.50M
$19.62B
$1.53B
$9.91B
$636.21M
Total Debt$8.97B
$380.00M
$19.40M

Expenses

RPRX Expenses
MetricDateValue
$1.61B
$814.82M
$3.85M
$0.00
$3.85M
$0.00
$0.00

Cash Flow

RPRX Cash Flow
MetricDateValue
$2.59B
-$1.71B
-$1.19B
Capex$1.70B
$897.24M

Recent analyst updates

RPRX Recent analyst updates
MetricDateValue
Citigroup→
TD Cowen→
Morgan Stanley→
Goldman Sachs
Citigroup→
Morgan Stanley→
Citigroup→
Goldman Sachs→
Morgan Stanley→
UBS→

Analyst sentiment

Sentiment over the past month
RPRX analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
RPRX institutional ownership distribution chart

Screeners with RPRX

FAQ

  • What is the ticker symbol for Royalty Pharma plc?

    The ticker symbol for Royalty Pharma plc is NASDAQ:RPRX

  • Does Royalty Pharma plc pay dividends?

    Yes, Royalty Pharma plc pays dividends. The last payment was $0.24, with an ex-dividend date on February 19, 2026

  • What sector is Royalty Pharma plc in?

    Royalty Pharma plc is in the Healthcare sector

  • What industry is Royalty Pharma plc in?

    Royalty Pharma plc is in the Biotechnology industry

  • What country is Royalty Pharma plc based in?

    Royalty Pharma plc is headquartered in United States

  • When did Royalty Pharma plc go public?

    Royalty Pharma plc initial public offering (IPO) was on June 16, 2020

  • Is Royalty Pharma plc in the S&P 500?

    No, Royalty Pharma plc is not included in the S&P 500 index

  • Is Royalty Pharma plc in the NASDAQ 100?

    No, Royalty Pharma plc is not included in the NASDAQ 100 index

  • Is Royalty Pharma plc in the Dow Jones?

    No, Royalty Pharma plc is not included in the Dow Jones index

  • When was Royalty Pharma plc last earnings report?

    Royalty Pharma plc's most recent earnings report was on February 11, 2026

  • When does Royalty Pharma plc report earnings?

    The next expected earnings date for Royalty Pharma plc is May 7, 2026

Data Sources & References

  1. RPRX Official Website www.royaltypharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276826000003/0001802768-26-000003-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276826000003/0001802768-26-000003-index.htm
  4. RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
  5. RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx